secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2026-08-13T20:25:42+00:00
Accession:  0001213900-26-089138
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical Q2 revenue up 127% to $1.3M; net loss $4.1M; closes $4.2M offering
--------------------------------------------------------------------------------

- Q2 revenue $1.3M (+127% YoY); gross profit $0.8M (64% margin vs 43% in Q2 2025).
- Net loss $4.1M ($12.35/share) vs $2.8M ($12.76/share) in Q2 2025; cash $1.7M at June 30.
- Closed $4.2M public offering July 1, net ~$3.6M; partial repayment of $5.2M convertible notes due Sept 11, 2026.
- FDA 510(k) clearance for Catamaran SI Joint Fusion System; record July case volume after 98% training-event increase.
- Effected 1-for-35 reverse stock split Aug 10; working to regain Nasdaq minimum bid price compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026089138/0001213900-26-089138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026089138/ea0301935-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-089138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer